Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04502433
Recruitment Status : Terminated (The enrolment has been extended 2 years but despite the Sponsor's attempts, the current infection status does not permit the identification of eligible patients for the study and to complete it in a reasonable time.)
First Posted : August 6, 2020
Last Update Posted : April 6, 2022
Information provided by (Responsible Party):
Chiesi Farmaceutici S.p.A.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 18, 2022
Actual Study Completion Date : March 18, 2022